Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gamma-thiaproline
2. Heparegen
3. Norgamem
4. Thiaproline
5. Thiazolidine-4-carboxylic Acid
6. Thiazolidine-4-carboxylic Acid, (r)-isomer
7. Thiazolidine-4-carboxylic Acid, Sodium Salt
8. Thioproline
1. Thiazolidine-4-carboxylic Acid
2. 444-27-9
3. 1,3-thiazolidine-4-carboxylic Acid
4. Detoxepa
5. Hepalidine
6. Thioproline
7. 4-thiazolidinecarboxylic Acid
8. Tiazolidin
9. Heparegene
10. Norgamem
11. Thiaproline
12. L-thiazolidine-4-carboxylic Acid
13. Dl-thiaproline
14. 4-carboxythiazolidine
15. Norgamen
16. Usaf C-1
17. T-4ca
18. Timonacic [inn]
19. Heptaladine
20. Timonacicum
21. Hepaldine
22. Heparegen
23. Timonacico
24. Usaf A-3701
25. Dl-thiazolidinecarboxylic Acid
26. Hepacom
27. Nsc 25855
28. Nsc-25855
29. Acide Thiazolidine-4-carboxylique
30. Thiazolidinecarboxylic Acid
31. Acide Dl Thiazolidine Carboxylique-4
32. Mfcd00128958
33. E5913t3ibl
34. Chebi:64564
35. Timonacic (inn)
36. Nsc25855
37. 4-thiazolidinecarboxylic Acid, L-
38. Timonacicum [inn-latin]
39. Timonacico [inn-spanish]
40. Thiazolidinecarboxylic Acid (van)
41. Einecs 207-146-6
42. Einecs 242-945-3
43. 4-thiazolidinecarboxylicacid
44. Thiazolidin
45. Unii-e5913t3ibl
46. Thiazolidine-4-carboxylicacid
47. Acide Thiazolidine-4-carboxylique [french]
48. Ccris 8099
49. Acide Dl Thiazolidine Carboxylique-4 [french]
50. L-4-thiazolidinecarboxylic Acid, 98%
51. Pidotimod Impurity
52. Hepacom (tn)
53. Timonacic [mi]
54. Timonacic [inci]
55. Timonacic [mart.]
56. 4-thiazolidincarboxylic Acid
57. Schembl8356
58. Timonacic [who-dd]
59. H-d-thz-oh;d-thioproline
60. Wln: T5m Cstj Evq
61. Thiazolidine-4-caboxylic Acid
62. Thiazolidin-4-carboxylic Acid
63. Chembl358722
64. Dtxsid9023675
65. Wln: T5m Cstj Evq -l
66. Dl-thiazolidine-4-carboxylic Acid
67. Hms3264c18
68. Pharmakon1600-01503320
69. Act03153
70. Albb-005988
71. Bcp13616
72. Hy-b1169
73. 1,3-thiazolidane-4-carboxylic Acid
74. Nsc758453
75. S4993
76. Stk361805
77. Akos000119343
78. Akos016040292
79. Racemic Thiazolidine-4-carboxylic Acid
80. 1,3-thiazolidine-4-carboxylic Acid #
81. Ab03779
82. Am81428
83. Ccg-213875
84. Cs-8024
85. Db12856
86. Nsc-758453
87. As-13539
88. Sbi-0207087.p001
89. 4-thiazolidinecarboxylic Acid, (.+/-.)-
90. Db-048659
91. Bb 0254773
92. Ft-0639201
93. Ft-0653153
94. Ft-0675152
95. Ft-0679172
96. A18785
97. D08601
98. D97373
99. Ab01563202_01
100. (r)-thiazolidine-4-carboxylic Acid;l-thioproline
101. 592t477
102. A876895
103. Ah-232/20359048
104. L(-)-thiazolidine-4-carboxylic Acid;l-thiaproline
105. Sr-01000944258
106. Sr-01000944258-1
107. Q23637400
108. Z955123540
109. 60731-25-1
Molecular Weight | 133.17 g/mol |
---|---|
Molecular Formula | C4H7NO2S |
XLogP3 | -2.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 133.01974964 g/mol |
Monoisotopic Mass | 133.01974964 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 106 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?